ASU’s Biodesign Institute And ImmuneRegen Collaborate To Investigate Possible Enhancement Of Vaccine Against Norwalk Viruses
August 25th, 2008 by 
admin ImmuneRegen® BioSciences, Inc., a totally owned supplementary of IR BioSciences Holdings, Inc. (OTCBB: IRBS), declared a collaborative relation with the Biodesign Institute at Arizona State University (ASU), Tempe, Ariz., to appraise the power of ImmuneRegen’s Viprovex® in boosting the insusceptible salutation when utilised as an adjuvant in union with unequalled plant-derived vaccines against noroviruses (also titled Norwalk-like viruses).
Tags: Led, Subsidiary
Posted in Immunology | 